BAY u9773
目录号 : KCM11658 CAS No. : 154978-38-8 纯度 : ≥95%
The biological effects of the cysteinyl leukotrienes (cysLTs, including LTC, LTD, and LTE) are transduced mainly by a pair of 7-transmembrane receptors, CysLT and CysLT BAY u9773 is a non-selective antagonist of the CysLT receptors, having about the same IC (20-80 nM) for the inhibition of LT responses in a variety of tissue preparations containing either/or both receptors. In contrast, many of the commercially developed CysLT receptor antagonists (pranlukast or montelukast) antagonize only CysLT receptors. BAY u9773 is thus one of the only available tools for blocking CysLT receptors.
规格 价格 是否有货 数量
25μg
In-stock
50μg
In-stock
100μg
In-stock
500μg
In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

BAY-u 9773 is a selective cysteinyl-leukotriene receptor antagonist. BAY-u 9773 competitively antagonizes cysteinyl-leukotriene-induced contractions at typical and atypical cysteinyl-leukotriene receptors with comparable activity. BAY-u 9773 can be used for the research of trichomoniasis.

体外研究

BAY u9773 (10 nM-10 μM; 15 minutes) competitively displaced [3H] leukotriene D4 binding to guinea pig lung membranes, with an average pKi of 7.0.
BAY-u 9773 (1-10 μM; 30-minute pretreatment) dose-dependently inhibited MCP-1 secretion induced by TvSP and LTC4 in HMC-1 cells, with the strongest effect observed at 10 μM.
BAY-u 9773 (1-5 μM) dose-dependently inhibited ROS production induced by TvSP and LTC4 in HMC-1 cells, with significant inhibition observed at concentrations ≥1 μM.
BAY-u 9773 (5 μM) can inhibit TvSP- and LTC4-induced HMC-1 cell migration, with an inhibition rate of approximately 60%.
BAY-u 9773 (1-5 μM) dose-dependently inhibited degranulation (detected by CD63 expression) induced by TvSP and LTC4 in HMC-1 cells, with the most potent effect at 5 μM.
BAY-u 9773 can inhibit TvSP-induced p47phox phosphorylation in HMC-1 cells.
BAY-u 9773 can inhibit NF-κB phosphorylation induced by TvSP and LTC4 in HMC-1 cells.

 

ELISA Assay

Cell Line: HMC-1
Concentration: 1 μM; 3 μM; 10 μM
Incubation Time: 30 min pretreatment
Result: Dose-dependently inhibited TvSP-induced MCP-1 secretion, reducing levels to ~260 pg/mL at 10 μM compared to ~460 pg/mL in untreated TvSP-stimulated cells.
Dose-dependently inhibited LTC4-induced MCP-1 secretion, reducing levels to ~270 pg/mL at 10 μM compared to ~460 pg/mL in untreated LTC4-stimulated cells.
体内研究

BAY-u 9773 (intravenous injection) can induce dose-dependent bronchoconstriction in anesthetized guinea pigs.

分子式
C27H36O5S
分子量
472.6
CAS号
154978-38-8
运输条件

Shipping with dry ice.

储存方式
-80°C
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积:

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。